Celyad Oncology SA (EBR: CYAD)
Belgium flag Belgium · Delayed Price · Currency is EUR
0.430
-0.020 (-4.34%)
Jan 31, 2025, 5:35 PM CET

Celyad Oncology Market Cap

Celyad Oncology has a market cap or net worth of €17.81 million as of January 31, 2025. Its market cap has increased by 21.47% in one year.

Market Cap
17.81M
Enterprise Value
12.57M
Revenue
72.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.43

Market Cap Chart

Since July 4, 2013, Celyad Oncology's market cap has decreased from 101.99M to 17.81M, a decrease of -82.53%. That is a compound annual growth rate of -13.98%.

History

DateMarket Cap% Change
Jan 31, 202517.81M-39.61%
Dec 31, 202429.50M82.56%
Dec 29, 202316.16M41.33%
Dec 30, 202211.43M-85.60%
Dec 31, 202179.42M-13.96%
Dec 31, 202092.30M-31.75%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
argenx SE 39.07B
UCB SA 35.71B
Financière de Tubize 6.80B
Fagron NV 1.40B
Ion Beam Applications 391.03M
Nyxoah 379.50M
Onward Medical 283.84M
Hyloris Pharmaceuticals 150.64M
Market Cap Rankings